600267 Zhejiang Hisun Pharmaceutical
- 7.91
- +0.14+1.80%
Zhejiang Hisun Pharmaceutical News
Zhejiang Hisun Pharmaceutical: Announcement of the subsidiary of Zhejiang Hisun Pharmaceutical Co., Ltd. obtaining the approval number for veterinary drug products.
Announcement of the resolution of the 16th meeting of the ninth supervisory committee of Zhejiang Hisun Pharmaceutical Co., Ltd.
Announcement of the resolution of the 29th meeting of the 9th Board of Directors of Zhejiang Hisun Pharmaceutical Co., Ltd.
Announcement of Zhejiang Hisun Pharmaceutical Co., Ltd. on the Consistency Evaluation of Its Pharmaceutical Products with Generic Drugs
Tianjian Certified Public Accountants LLP's special general partnership explanatory statement on the information disclosure supervision work letter regarding Zhejiang Hisun Pharmaceutical Co., Ltd.'s 2023 Annual Report.
Announcement of the resolution of the 28th meeting of the 9th board of directors of Zhejiang Hisun Pharmaceutical Co., Ltd.
Announcement of zhejiang hisun pharmaceutical co., LTD. about its subsidiary receiving government subsidies.
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. receiving a reply regarding the renewal of the accounting firm
Zhejiang Haizheng Pharmaceutical Co., Ltd. 2023 Social Responsibility Report
Zhejiang Haizheng Pharmaceutical Co., Ltd. 2023 Internal Control Audit Report
Special inspection opinions on the deduction of operating income
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on the former director and president of the company being investigated by relevant departments
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on the forecast of daily related transactions in 2024
Announcement of Resolutions of the 15th Meeting of the 9th Board of Supervisors of Zhejiang Haizheng Pharmaceutical Co., Ltd.
Special audit report on the summary table of non-operating capital occupation and other related capital transactions of Zhejiang Haizheng Pharmaceutical Co., Ltd.
Special note by the board of directors of Zhejiang Haizheng Pharmaceutical Co., Ltd. on matters involving non-standard audit opinions on the company's 2023 financial report
Special note on issuing a non-standard audit opinion on the 2023 financial statements of Zhejiang Haizheng Pharmaceutical Co., Ltd.
Opinions of the Supervisory Board of Zhejiang Haizheng Pharmaceutical Co., Ltd. on the “Special Instructions of the Board of Directors on Matters Involving Non-standard Audit Opinions on the Company's 2023 Financial Report”
Zhejiang Haizheng Pharmaceutical Co., Ltd. Independent Director's 2023 Debriefing Report (Yang Lirong)
2023 Annual Debriefing Report of the Independent Director of Zhejiang Haizheng Pharmaceutical Co., Ltd. (Zhou Huali)
Analysis
Price Target
No Data
